MDMA administration and heat shock proteins response: foreseeing a molecular link.
Current Pharmaceutical Biotechnology August 1, 2010
MDMA administration and heat shock proteins response: foreseeing a molecular link.
Page 124 of 345: studies 1,231 to 1,240 of 3,446, newest first. Back to the MDMA overview
Current Pharmaceutical Biotechnology August 1, 2010
MDMA administration and heat shock proteins response: foreseeing a molecular link.
Current Pharmaceutical Biotechnology August 1, 2010
Causes and effects of cellular oxidative stress as a result of MDMA abuse.
Current Pharmaceutical Biotechnology August 1, 2010
Mice in ecstasy: advanced animal models in the study of MDMA.
Clinical Toxicology August 2010 Donna Seger
This article reviews the role and clinical importance of specific neuroadaptations that may occur following use of cocaine, metamfetamine, and 3,4,methylenedioxymetamfetamine (MDMA). A literature search was performed using OVID MEDLINE and PubMed for all years to the present date, which identified 250 papers of which 154 were considered relevant. MECHANISMS OF ACTION OF COCAINE AND...
Addiction August 1, 2010 Udo Benzenhöfer, Torsten Passie 69 citations
ABSTRACTAims Alexander T. Shulgin is widely thought of as the ‘father’ of +/−3,4‐methylenedioxymethamphetamine (MDMA). This paper re‐assesses his role in the modern history of this drug.Methods We analysed systematically Shulgin's original publications on MDMA, his publications on the history of MDMA and his laboratory notebook.Results According to Shulgin's book PIHKAL (1991), he synthesized...
Psychopharmacology July 20, 2010
Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
Journal of Psychopharmacology July 19, 2010 Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer et al. 672 citations
Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as 'Ecstasy' resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct. Twenty patients with chronic posttraumatic stress disorder,...
Journal of Pharmacology and Experimental Therapeutics July 16, 2010 Bethann N. Johnson, Bryan K. Yamamoto 22 citations
Stress facilitates drug abuse by humans. In rodents, stress enhances the neurochemical, neuroendocrine, and behavioral responses to psychostimulants. Although chronic unpredictable stress (CUS) enhances the acute hyperthermic and long-term monoamine-depleting effects of the psychostimulant +3,4-methylenedioxymethamphetamine (MDMA), the roles of hyperthermia and corticosterone (CORT) in...
European Journal of Pharmacology July 13, 2010
Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain.
Developmental Neuroscience July 10, 2010
Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain.